A Phase 1, Crossover Study to Evaluate the Pharmacokinetics of Corplex Donepezil 10 mg Transdermal Delivery System Applied to Different Body Locations.
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Corium International
- 06 Aug 2018 Status changed from recruiting to completed.
- 15 Feb 2018 New trial record